Development of In Vivo Model of Intraocular Retinoblastoma.

Here we describe creation of a model of intraocular retinoblastoma on 4 mature immunodeficient BALB/c nude mice of both sexes. A suspension of the primary retinoblastoma culture was injected into each of the 8 eyes of the test animals. The injections were performed under the control of an operating microscope using insulin syringes with a diameter of 29G transsclerally into the subretinal space in a volume of 0.3 ml at a rate of 10,000 cells in 25 µl physiological saline. The culture of Rb10 cells derived from a patient with retinoblastoma passed 12 passages at the time of the experiments. After 9-week follow-up, a clinical (ophthalmoscopy) and instrumental (ultrasound) study was performed with visualization of the tumor mass on the fundus. After enucleation, a morphological study was performed. The retinoblastoma tumor nodes were identified in two eyes. The proposed model can be used for further research and for testing new chemotherapeutic drugs and treatment regimens for retinoblastoma.

Retinoblastoma Cell Culturing and Evaluation of Their Drug Resistance.

We obtained primary culture of retinoblastoma cells and evaluated the resistance of cultured ells to chemotherapy. The study included 19 patients aged 6-64 months (mean 27.9±17.4 months); of these, 6 (31.6%) patients with bilateral retinoblastoma and 13 (68.4%) patients with unilateral form. In 18 (94.7%) patients, group E retinoblastoma was diagnosed. Enucleation was performed in all patients; in 94.7% cases, low-differentiated retinoblastoma was identified. Samples of the tumor tissue were taken to derive a cell culture and to study drug resistance and metabolic activity of cells (MTT test). In 4 cases, adhesion primary cultures of retinoblastoma were derived. Cytological verification of the obtained cultures was performed. The primary cultures were derived from 4 of 6 bilateral tumors and from none of 13 unilateral tumors (p=0.003). There were no statistically significant correlations with patient age (p=0.33) and the presence of calcifications in the tumor (p=0.26). MTT test revealed no differences in the sensitivity of cell cultures to irinotecan and ifosfamide. Pronounced differences in the resistance of cell cultures were observed for oxaliplatin and ascorbic acid. MTT test with evaluation of drug resistance can be used both in clinical practice for adjusting chemotherapy regimen and in development of new approaches to the treatment of retinoblastoma with assessment of in vivo tumor cell resistance in animal models.

[Non-Hodgkin lymphoma (a case of simultaneous ocular and orbital involvement)].

The paper presents an integrated analysis of clinical, instrumental, and morphological data on a very rare pathological condition-- simultaneous ocular and orbital involvement in a lymphoproliferative disorder.

[Intraocular schwannoma case report: clinical and pathomorphological analysis].

The paper presents a complete clinical, instrumental, histopathological, immunohistochemical, cytological, and molecular-genetic testing of intraocular schwannoma in a 13-year-old girl.

[Diagnostic possibilities of fine-needle aspiration biopsy in malignant tumors of the orbit]. / Diagnosticheskie vozmozhnosti tonkoigol'noi aspiratsionnoi biopsii pri zlokachestvennykh opukholiakh orbity.

Cytological studies were carried out in 94 patients with malignant tumors of the orbit using fine-needle aspiration biopsy. Diagnostic potentialities of the method are shown. The method possesses the highest diagnostic informative value in evaluation of the type of the process (98.8%). Cytological characteristics of the most incident malignant tumors of the orbit are presented.